Mr. Peter Copetti reports

POET TECHNOLOGIES ANNOUNCES APPOINTMENT OF CHIEF EXECUTIVE OFFICER ("CEO")

Poet Technologies Inc. has appointed Dr. Suresh Venkatesan as chief executive officer of the company. Dr. Venkatesan will commence his new position immediately.

Dr. Suresh Venkatesan was most recently senior vice-president, technology development, at GlobalFoundries and was responsible for the company's technology research and development. Dr. Venkatesan joined GlobalFoundries in 2009, where he led the development and ramp of the 28-nanometre node and was instrumental in the technology transfer and qualification of 14 nm. In addition, he was responsible for the qualification and ramp-up of multiple mainstream value-added technology nodes.

Dr. Venkatesan is an industry veteran with over 22 years of experience in semiconductor technology development. Prior to joining GlobalFoundries, he held various leadership positions with Freescale Semiconductor in Austin, Tex. Dr. Venkatesan holds over 25 United States patents, and has co-authored over 50 technical papers. He holds a bachelor of technology degree in electrical engineering from the Indian Institute of Technology and MSc and PhD degrees in electrical engineering from Purdue University.

Peter Copetti, who has been serving as interim chief executive officer since February, 2014, will continue to serve as the company's executive co-chairman.

"We are extremely pleased to have Suresh join the company as our chief executive officer. He has the unique skill set of product and device development and a deep understanding of the physics involved in the process. We have been looking for over one year for the perfect permanent chief executive officer and I believe we have found that person. He brings tremendous leadership and foundry industry development and strategy experience. This is a critical milestone in the company's succession plan as we continue our lab-to-fab transition," noted Peter Copetti, executive co-chairman of the company.

Dr. Venkatesan commented: "I see immense market potential for Poet Technology's III-V complementary semiconductor fabrication process. The industry is at inflection point where new innovative solutions are needed. Integrating electronics and optical devices on the same chip monolithically can revolutionize many segments of the semiconductor market. I am excited to be part of the team."

Dr. Geoff Taylor, Poet founder, added: "On behalf of the board of directors, I would like to express our most sincere thanks to Peter for his vision and his determination to take Poet to the next level. The financial turnaround of the company was remarkable and is now complete. We are now focused on product development and achieving revenue. Peter raised the bar every day and executed tirelessly toward his vision for the company. He has assembled a great team both at the board of directors level and at the Poet executive level which has substantially augmented our semiconductor industry experience to deliver on the Poet Technology for our shareholders."

Dr. Venkatesan was granted 6,357,082 options to purchase common shares of the company. The options may be exercised at a price of $1.40 per share for a term of five years from the effective date of his employment, expiring on June 10, 2020. The option terms were determined based on current market price in accordance with the TSX Venture Exchange policies and the company's stock option plan and the options will vest as follows: 908,154 options on the first anniversary of the effective date, 681,116 options on the 18th month anniversary of the effective date, 681,116 options on the 24th month anniversary of the effective date, and 1,021,674 options on the 30th, 36th, 42nd and 48th month anniversary of the effective date.

We seek Safe Harbor.